Event details
Thank you for your interest in this webinar organised and funded by Ascendis Pharma for UK HCPs only on Wednesday 1st July 2026 from 18:30–19:30 BST.
This meeting will provide a forum to explore what is currently missing in the management of hypoparathyroidism and discuss how emerging clinical evidence, including Yorvipath® (palopegteriparatide), may help address unmet needs in patient care.
Meeting objectives- Describe the key unmet needs in hypoparathyroidism and limitations of current management approaches
- Interpret the clinical evidence in the context of unmet needs
- Translate evidence into practice using a real‑world patient case
Speakers
Dr Alex Lewis
Dr Alex Lewis is a Consultant Endocrinologist at Manchester University NHS Foundation Trust. He completed specialist training in diabetes, endocrinology, and internal medicine in 2021, and following a consultant appointment, he has run several projects to transform service development within the endocrinology department at Manchester Royal Infirmary. He is invested in improving care pathways for patients to ensure patients can be seen when they need to be and optimise patient safety, monitoring, experience, and outcomes in those with chronic endocrine disease.
Dr Lewis has a broad interest across endocrinology, including specialist interests in thyroid and parathyroid disease, reproductive endocrinology, and endocrine genetic syndromes. He regularly joins the regional pituitary and andrology multidisciplinary meetings to improve patient care. Dr Lewis also teaches in the undergraduate medical course at the University of Manchester Medical School and within specialist training programmes. Dr Lewis is a member of the Society for Endocrinology and has presented at international conferences on specialist interest areas.
Dr Lisa Yang
Dr Lisa Yang is a Consultant Endocrinologist at Cambridge University Hospitals NHS Trust. She co-chairs the regional adrenal MDT and leads clinics in reproductive endocrinology, bone and calcium disorders.
Dr Yang completed her specialty training in North-West London and was awarded a PhD from Imperial College London. She has authored numerous publications in the field of reproductive endocrinology, human brain function, and bone metabolism.
Dr Anand Velusamy
Dr Anand Velusamy is a Consultant Endocrinologist at Guy’s and St Thomas’ NHS Foundation Trust, London, with specialist expertise in thyroid disease, parathyroid disorders, and neuroendocrine tumours. He has advanced skills in thyroid fine needle aspiration and is an active member of the Southeast London Thyroid Cancer Network.
He has a strong focus on clinical and commercial research, working at the interface of academia and industry to drive innovation, support high-impact trials, and accelerate the translation of scientific advances into clinical practice. Dr Velusamy is a member of both the Corporate Liaison Committee and the Events and Training Committee of the Society for Endocrinology, where he contributes to strategic industry engagement, professional education, and the development of high-quality endocrine training initiatives.
|
|
|